Scientists at Mumbai’s Tata Memorial Centre, a renowned cancer treatment and research institution, have unveiled a groundbreaking discovery in cancer therapy. They assert that they have formulated a pill capable of reducing cancer recurrence by 30%, with a price tag as low as Rs 100. Moreover, this tablet purportedly slashes the adverse effects of radiation and chemotherapy by at least 50%.
A Decade of Research of Tata Memorial Centre
According to Dr. Rajendra Badve, a surgeon and senior scientist at the Tata Memorial Centre, the research team dedicated a decade to developing this revolutionary tablet, which he claims is the most economical cancer treatment option in the nation.
Effective Against Specific Cancers
Particularly effective for cancers affecting the mouth, lungs, and pancreas, the researchers have submitted an application to the Food Safety and Standards Authority of India (FSSAI) for approval. They anticipate its availability in the market within three months. However, patients may have to wait several more years before utilizing this tablet for cancer recurrence treatment.
Experimental Procedure of Cancer Treatment Pill
The experiment involved injecting human cancer cells into mice, followed by chemotherapy and radiotherapy. These treatments destroyed the cancer cells, converting them into chromatin molecules. Dr. Badve elaborated that these molecules circulated throughout the body via the bloodstream, infiltrating healthy cells to combat cancer.
Awaiting Regulatory Approval and availability for the public
The tablet’s potential availability is contingent upon FSSAI approval, with Tata doctors and scientists from the Tata Institute of Fundamental Research (TIFR) aiming for a market launch between June and July.
Promising Future Prospects of Cancer Treatment Pill
This innovation holds promise not only for curbing cancer recurrence but also for mitigating treatment side effects, especially for pancreatic, lung, and oral cancers. Representing a significant advancement in cancer care, its affordability and efficacy could revolutionize oncology practices, offering hope to patients worldwide.
What are cell free chromatin particles?
Cell-free chromatin particles refer to fragments of chromatin, the complex of DNA and proteins that makeup chromosomes, found outside of cells in bodily fluids such as blood or urine. These particles can be released into circulation through various cellular processes, including cell death, apoptosis, or necrosis.
They may also originate from circulating immune cells or other sources. Cell- free chromatin particles contain genetic material and associated proteins, and their presence in bodily fluids can serve as biomarkers for various diseases, including cancer, autoimmune disorders, and inflammatory conditions, providing valuable insights into disease diagnosis, prognosis, and treatment monitoring
